Subject:
|
DCN 1: Perception and Action DCN 2: Functional Neurogenomics DCN 3: Neuroinformatics N4i 1: Pathogenesis and modulation of inflammation NCEBP 11: Alzheimer Centre UMCN 3.1: Neuromuscular development and genetic disorders UMCN 3.2: Cognitive neurosciences UMCN 4.1: Microbial pathogenesis and host defense |
Abstract:
|
We describe 2 children with postinfectious opsoclonus-myoclonus syndrome. Although the patients initially responded to monotherapy with methylprednisolone, intravenous immunoglobulins, or rituximab, they manifested persistent neurologic deficits and relapsing signs. Treatment with rituximab in combination with intravenous immunoglobulin, however, resulted in significant longterm clinical improvement.
|